Northwestern to explore personalized medicine for scleroderma.
Posted 04 January 2012 - 02:47 PM
Northwestern is one of four sites to receive funding through the new NIH grants. Northwestern will serve as the lead institution for proteomics research and will explore biomarkers at the protein level. EurekaAlert, 12/01/11. (Also see: Biomarkers)
This item was posted in the ISN Newsroom. Please check the newsroom daily for updates on scleroderma and other related articles.
ISN Assistant Webmaster
ISN Sclero Forums Manager
ISN News Manager
ISN Hotline Support Specialist
ISN Chat Host
International Scleroderma Network (ISN)